Amplify Weight Loss Drug & Treatment ETF THNR
26.27 USD +0.36 (+1.39%)
At closeNov 9, 2026, 5:30 PM EST
27.01 +0.74 +2.80%
After hours · Nov 9, 5:30 PM ET
26.27 Day range 26.27
23.40 52-week range 27.94
- YTD
- +4.18%
- 1 year
- +11.81%
News
etftrends.com Eli Lilly, Regeneron Lead Weight-Loss ETF THNR Higher The Amplify Weight Loss Drug & Treatment ETF (THNR) returned 3.2% in October, according to Amplify ETFs. Eli Lilly and Co. (LLY) drove most of that gain, after reporting quarterly results that beat…
etftrends.com What the Holidays Hold for GLP-1 Stocks in THNR The holiday season is almost here and will soon be followed by the annual surge in New Year's resolutions. This will likely drive renewed interest in GLP-1 products, especially as new oral GLP-1…
benzinga.com Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval Food makers and restaurants adjust menus and products as GLP-1 drugs drive demand for high-protein foods and smaller portions across the U.S.